A rare and critical nerve condition known as Osimertinib ( drug )-induced worsening multifocal white matter encephalitis (PML) is associated with the use of Osimertinib ( drug ), which is a targeted therapy for Non small-cell lung malignancy (NSCLC).Characterized by of the central nervous system by the John Cunningham (JC) virus, this condition presents important hurdles in its detection, care, and avoidance.The main trigger of Osimertinib ( drug )-induced PML is the resurgence of the JC virus in weakened immune patients who are receiving Osimertinib ( drug ).The virus remains…
